Author
Iwan C.C. van der Horst
Also Known As
Adrian Wong, Chris P. H. Lexis, Frederik Keus, I C C Van Der Horst, I C C van der Horst, I. C. C. Van Der Horst, I. C. C. van der Horst, I. C.C. van der Horst, I.C.C Van Der Horst, I.C.C van der Horst
343
Publications
13.8K
Citations
55
H-Index
126
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 25 | 41 | 2.4K |
2 | Health Sciences | 6 | 6 | 297 |
3 | Nursing | 2 | 2 | 69 |
4 | Business | 1 | 1 | 60 |
5 | Engineering | 1 | 1 | 34 |
Iwan C.C. van der Horst
×
143
Publications
7.9K
Citations
48
H-Index
| Year | Citations | |
|---|---|---|
2019 | 514 | |
2018 | 327 | |
2011 | 304 | |
2003 | 260 | |
2011 | 241 | |
2021 | 208 | |
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial Alexander P. J. Vlaar, Sanne de Bruin, Matthias H. Busch, Clinical Infectious DiseaseCovid-19 PandemicImmunologyClinical TrialsSevere Covid-19 | 2020 | 198 |
2013 | 180 | |
2014 | 179 | |
2019 | 179 |
Page 1
Page 1